Search Results
Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of MIBC patients
Phase-2 trial of gemcitabine, cisplatin + nivolumab with selective bladder sparing in MIBC patients
HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder s...
Nivolumab, Gemcitabine & Cisplatin for Patients w Muscle-Invasive Bladder Cancer Undergo Cystectomy
Receiving Carboplatin and Gemcitabine for cancer
Exploring Bladder-Sparing Treatment Approaches in MIBC
New and Emerging Therapeutic Strategies in Bladder Cancer
Neoadjuvant Immune Checkpoint Inhibition for Muscle Invasive Bladder Cancer
Case-Based Panel Discussion: Muscle-Invasive Bladder Cancer
Therapeutic Advances in Patient Care for Early to Advanced Bladder Cancer
State of the Art - Neoadjuvant chemotherapy becoming standard of care in MIBC?
Cisplatin: An Effective Chemotherapy Drug with Side Effects and Challenges | GlpBio
